Cosgrove Delos M.

Director · HIMS, AMWL

As of 2026-09-16, Cosgrove Delos M. has 10 Form 4 transactions on record across 2 companies — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $1.2MIndirect: $0$1.2Mas of 2026-09-16
  • Direct $1.2M
  • Indirect $0
AMWLdirect71,193 sh$949K
HIMSdirect8,223 sh$230K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

HIMS · 8 trades
2026-08-12: Award / grant, 8,223 sh ($0)2026-06-11: Option exercise, 3,656 sh ($0)2026-06-11: Option exercise, 3,656 sh2026-06-11: Option exercise, 3,656 sh2025-08-06: Award / grant, 3,656 sh ($0)2025-06-12: Option exercise, 9,935 sh ($0)2025-06-12: Option exercise, 9,935 sh2025-06-12: Option exercise, 9,935 sh
AMWL · 2 trades
2026-06-16: Award / grant, 14,501 sh ($0)2025-06-11: Award / grant, 20,891 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
10 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-08-12HIMSAward / grant8,2238,223Form 4
2026-06-16AMWLAward / grant14,50171,193Form 4
2026-06-11HIMSOption exercise3,6560Form 4
2026-06-11HIMSOption exercise3,65667,995Form 4
2026-06-11HIMSOption exercise3,65667,995Form 4
2025-08-06HIMSAward / grant3,6563,656Form 4
2025-06-12HIMSOption exercise9,9350Form 4
2025-06-12HIMSOption exercise9,93564,339Form 4
2025-06-12HIMSOption exercise9,93564,339Form 4
2025-06-11AMWLAward / grant20,89156,692Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.